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Identification of patients at high risk  
for hypocalcemia after total thyroidectomy
Identificazione dei pazienti ad alto rischio di ipocalcemia dopo tiroidectomia totale
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SummAry
hypocalcemia is a major post-operative complication of total thyroidectomy, causing severe symptoms and increasing hospitalization time. 
The primary cause is secondary hypo-parathyroidism following damage to, or devascularisation of, one or more parathyroid glands during 
surgery. Aim of the study was to develop a simple and reliable method for predicting post-operative hypocalcemia in total thyroidectomy 
patients. A retrospective analysis was made of immediate pre-operative and early post-operative calcium levels in 100 patients. it was found 
that a marked decrease in blood calcium, immediately after surgery, was a sensitive predictor of hypocalcemia. in a subsequent prospective 
series of 67 patients, the efficacy was assessed of early administration of calcium plus Vitamin D in reducing symptomatic hypocalcemia in 
patients in whom the difference (Δ) between pre- and post-operative blood calcium was ≥ 1.1 mg/dl. This treatment was part of a protocol 
in which normo-calcemic patients were discharged immediately after drainage removal (third post-operative day).
in the retrospective series, 84% of patients who developed hypocalcemia had Δ ≥ 1.1 and 54% of patients who did not develop hypocal-
cemia had Δ < 1.1 (p < 0.0001). mean duration of hospitalization was 6.2 days. in the prospective series, 76% of patients who developed 
hypocalcemia had Δ ≥ 1.1 mg/dl; of the patients who did not develop hypocalcemia 75% had Δ < 1.1 mg/dl (p = 0.0013); mean hospi-
talization was 4.7 days (p < 0.0001). use of the 1.1 mg/dl cut-off for deciding whether to start early prophylaxis allowed most patients to 
avoid symptomatic hypocalcemia (and the associated anxiety), while permitting a significantly reduced hospital stay, resulting in lower 
hospitalization costs.
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riASSunTo
L’ipocalcemia è la complicanza post-operatoria più frequente negli interventi di tiroidectomia totale, causando gravi sintomi e aumentando 
il tempo di ospedalizzazione. La causa principale è l’ipoparatiroidismo secondario dovuto al danneggiamento o alla devascolarizzazione 
di una o più ghiandole paratiroidi durante l’intervento chirurgico. Abbiamo cercato di sviluppare un metodo semplice e affidabile per pre-
dire l’ipocalcemia post-operatoria in pazienti sottoposti a tiroidectomia totale. Sono stati analizzati retrospettivamente i livelli di calcemia 
nell’immediato pre-operatorio e precocemente nel post-operatorio in 100 pazienti. Abbiamo notato che una significativa diminuzione della 
calcemia subito dopo l’intervento chirurgico era un fattore predittivo di ipocalcemia. In una successiva serie prospettica di 67 pazienti, è 
stata valutata l’efficacia della somministrazione precoce di calcio più vitamina D per ridurre l’ipocalcemia sintomatica nei pazienti in cui 
la differenza (Δ) tra il calcio nel sangue pre- e post-operatorio era ≥ 1,1 mg/dl. Questa terapia faceva parte di un protocollo nel quale i 
pazienti normocalcemici venivano dimessi immediatamente dopo la rimozione del drenaggio (terza giornata post-operatoria). Nella serie 
retrospettiva, l’84% dei pazienti che avevano sviluppato l’ipocalcemia aveva Δ ≥ 1,1 e il 54% dei pazienti che non mostrava l’ipocalcemia 
aveva Δ < 1,1 (p < 0,0001). La degenza media è stata di 6,2 giorni. Nella serie prospettica, il 76% dei pazienti che aveva sviluppato l’ipo-
calcemia mostrava un Δ ≥ 1,1 mg/dl; dei pazienti che non avevano sviluppato l’ipocalcemia, il 75% aveva un Δ < 1,1 mg/dl (p = 0,0013); 
la degenza media è stata di 4,7 giorni (p < 0,0001). L’utilizzo del valore 1,1 mg/dl come cut-off per decidere se avviare precocemente la 
terapia calcica ha permesso alla maggior parte dei pazienti di evitare l’ipocalcemia sintomatica (e l’ansia ad essa associata), riducendo 
anche in modo significativo la degenza post-operatoria con conseguente riduzione dei costi di ospedalizzazione.
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Introduction
hypocalcemia  remains  a  major  post-operative  compli-
cation of total thyroidectomy causing potentially severe 
symptoms and anxiety in affected patients and increas-
ing hospitalization time. Transient hypocalcemia, often 
observed after the operation, generally responds favour-
ably to replacement therapy within a few days or weeks 1. 
hypocalcemia is considered permanent when it does not 
return  to  normal  within  6  months  (1.3-3%  of  cases) 2. 
The primary cause of hypocalcemia is secondary hypo-
parathyroidism following damage to, or devascularisation predicting hypocalcemia after total thyroidectomy
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of, one or more parathyroid glands during surgery. erro-
neous parathyroid removal may also be responsible 3-11. 
risk factors for post-operative hypocalcemia following 
total thyroidectomy include thyroid gland size, substernal 
extension of the thyroid, type of thyroid disorder, extent 
of surgery, and whether re-operation is necessary 3-10. hy-
pocalcemia can be asymptomatic, particularly if calcium 
levels are only mildly reduced, or symptomatic with typi-
cal manifestations such as Chvostek’s and Trousseau’s 
signs,  muscle  spasms  and  paresthaesia.  Severe  neuro-
logical manifestations may occur if the condition is not 
adequately treated. post-operative hypocalcemia requires 
calcium and Vitamin D supplementation, with monitoring 
until blood calcium returns to normal, thus hospitalisation 
is typically prolonged. Calcium, with Vitamin D, may be 
administered for prophylactic purposes but is useless if 
blood calcium is normal and carries the risk of triggering 
hypercalcemia.
The aims of the present study were two: a) identify pa-
tients at high risk of developing hypocalcemia following 
total thyroidectomy by means of retrospective analysis of 
early post-operative calcium levels; b) to assess the ef-
ficacy of early prospective administration of calcium and 
Vitamin D in reducing symptomatic post-operative hy-
pocalcemia and hospitalization time 10 in patients consid-
ered at high risk of developing hypocalcemia based on the 
findings of the retrospective study.
Materials and methods
A retrospective analysis was made of pre- and post-oper-
ative calcium levels in 100 consecutive patients who had 
been submitted to total thyroidectomy at the Thyroid unit, 
Division of head and neck Surgery, european institute of 
oncology, between 2002 and 2004. From 2006 to 2007, 
93 consecutive patients were studied prospectively.
The inclusion criterion for both series was total thyroidec-
tomy with or without neck/level Vi dissection. exclusion 
criteria were: abnormal serum albumin (above or below 
the  normal  range  of  3.4-4.8  g/dl),  abnormal  pre-oper-
ative calcium (above or below the normal range of 8.0-
10.4 mg/dl (2.00-2.6 mmol/l) in the retrospective series, 
and 8.8-10.2 mg/dl in the prospective series); abnormal 
pre-operative parathyroid hormone levels (above or below 
the normal range of 9.5-75 pg/ml); renal insufficiency and 
pre-operative calcium replacement.
in all retrospective cases, the following parameters were 
assessed: pre- and post-operative serum calcium levels 
(morning and afternoon of all post-operative hospitaliza-
tion days), presence of one or more parathyroid glands 
in the surgical specimen, presence of post-operative signs 
and symptoms of hypocalcemia, post-operative day on 
which patient became symptomatic (when calcium and 
Vitamin D supplementation started) and hospitalization 
time.
patients operated upon after 2005 were monitored accord-
ing to a new schedule established following an analysis 
of outcomes in the retrospective series. hypocalcemia, 
number of blood calcium determinations, hospitalization 
time, and treatment costs were compared in the retrospec-
tive and prospective series.
Results
Retrospective series
mean duration of hospital stay was 6.19 days (standard 
deviation 0.24), including one day prior to surgery. All 
patients had normal (9.5-75 pg/ml) pre-operative parathy-
roid hormone and normal calcium levels (8.0-10.4 mg/
dl). A total of 50 (50%) patients developed hypocalcemia 
(< 8.0 mg/dl) after surgery, of these 24 were symptomatic 
and 26 asymptomatic (Table i). of the 24 patients who 
developed symptomatic hypocalcemia, 3 (12.5%) did so 
on the first day after surgery. A total of 24 patients de-
veloped  symptomatic  hypocalcemia,  3  (12.5%)  on  the 
first day after surgery, 15 (62.5%) on the second day, 4 
(17%) on the third day and one (4%) each on the fourth 
and fifth days (Table ii). in all cases, treatment was started 
on the same day as onset of symptoms and consisted of a 
single i.v. administration of calcium gluconate (40 meq 
in 100 ml physiological solution) with subsequent twice 
daily oral administration of calcium and Vitamin D. of 
the patients who developed asymptomatic hypocalcemia, 
Table I. Frequency of hypocalcemia in retrospective and prospective 





Total number of patients (%) 100 67
Number hypocalcemic (%) 50 (50%) 55 (82.1%)
Number symptomatic (%) 24 (24%) 13 (19.4%)
Number asymptomatic (%)  26 (26%) 41 (61.2%)
Not assessed (%) 0 (0%) 1 (1.5%)
Table  II.  Distribution  of  appearance  of  hypocalcemia  in  the  50 














First day 3 (12.5%) 1 (4%)
Second day 15 (62.5%) 8 (31%)
Third day 4 (17%) 7 (26%)
Fourth day 1 (4%) 2 (8%)
Fifth day 1 (4%) 0
No post-op. Ca therapy 0 8 (31%)
Total  24 26p. Tredici et al.
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one (4%) started treatment on the first, 8 (31%) on the 
second, 7 (26%) on the third, and 2 (8%) on the fourth 
post-operative day; in all cases, on account of abnormally 
low calcium levels. eight of the 26 (31%) asymptomatic 
hypocalcemic patients were not treated.
A total of 26 (26%) patients had parathyroid tissue in the 
surgical specimen, 13 of these developed hypocalcemia 
and 13 remained normocalcemic. of the 50 patients who 
developed  hypocalcemia,  8  (15%)  had  2  parathyroids 
in the specimen, and 42 (85%) had 1 parathyroid in the 
specimen. of the 50 patients who did not develop hypo-
calcemia, 8 (15%) presented 2 parathyroid glands in the 
specimen and 42 (85%) had one parathyroid gland in the 
specimen.
of the 24 symptomatic hypocalcemia patients, 17 had no 
parathyroids removed, 6 had one parathyroid removed 
and one had 2 parathyroids removed. of the 26 asymp-
tomatic hypocalcemia patients, 20 had no parathyroids 
removed, 5 had one parathyroid removed and one had 
2 parathyroids removed. From these data, hypocalcemia 
appeared  independent  from  parathyroid  tissue  in  the 
specimen.
it was found that the greatest decrease in post-operative 
serum calcium levels, compared to pre-operative levels, 
occurred on the morning of the first post-operative day 
(12-18 hours after the operation). we, therefore, evalu-
ated, for each patient, the difference (Δ) between pre-
operative serum calcium and the level on the first post-
operative  assessment  (usually  the  morning  of  the  first 
post-operative day). Thereafter, an attempt was made to 
identify a threshold value of Δ which would best sepa-
rate patients who became hypocalcemic from those who 
did not. First of all, the mean value was investigated of Δ 
(1.4 mg/dl) as possible cut-off (Table iii). using Fisher’s 
exact test, patients with Δ ≥ 1.4 mg/dl were significantly 
more likely (p < 0.0001) to develop hypocalcemia than 
those with Δ < 1.4 mg/dl. nevertheless, 11 patients with 
Δ < 1.4 mg/dl developed hypocalcemia. To reduce this 
number (i.e., increase sensitivity at the cost of reducing 
specificity) it was decided to lower the cut-off for Δ to 
the arbitrary value of 1.1 mg/dl, when only 8 patients be-
low this cut-off developed hypocalcemia (Table iV). with 
the new threshold, patients with Δ ≥ 1.1 mg/dl were still 
significantly more likely (p < 0.0001) to develop hypoc-
alcemia than those with Δ < 1.1 mg/dl. in fact, of the 50 
patients who developed hypocalcemia, 42 (84%) present-
ed a decrease (Δ) of ≥ 1.1 mg/dl. And of the 50 patients 
who did not develop hypocalcemia, 23 (46%) presented 
a decrease of ≥ 1.1 mg/dl and 27 (54%) a decrease of 
< 1.1 mg/dl (Table iii).
New post-operative monitoring protocol
A threshold of 1.1 mg/dl was adopted and a new protocol 
was elaborated for the management of post-operative hy-
pocalcemia which was designed to reduce symptomatic 
hypocalcemia and also reduce hospitalization time. The 
protocol is shown in Table iV.
Prospective series
enrolled in the prospective study, were 93 patients, how-
ever only 67 were evaluable as pre-operative calcium lev-
els were not determined in 33. of the 55/67 patients who 
developed hypocalcemia, 42/55 (76%) had Δ ≥ 1.1 mg/dl; 
of the 12/67 patients who remained normocalcemic 9/12 
(75%) had Δ < 1.1 mg/dl (Table V). The difference in hy-
pocalcemia incidence between the two groups, defined by 
the 1.1 mg/dl cut-off, was significant (p = 0.0013; Fisher’s 
exact test).
Application  of  the  protocol  (Table  iV)  was  associated 
with a mean hospital stay of 4.73 (SD 0.18) days, includ-
ing the day prior to surgery. The difference in duration of 
hospital stay, between the retrospective and prospective 
series, was significant (p < 0.0001, Student t test). The 
mean number of serum calcium measurements per patient 
Table III. Distribution of hypocalcemia and normocalcemia in retrospec-
tive series of patients undergoing total thyroidectomy, according to the 










1.4 Δ ≥ 1.4 39 (78.0%) 12 (24.0%) 51
Δ < 1.4 11 (22.0%) 38 (76.0%) 49
1.1 Δ ≥ 1.1 42 (84.0%) 23 (46.0%) 65
Δ < 1.1 8 (16.0%) 27 (54.0%) 35
* Hypocalcemia defined as < 8.0 mg/dl; ** normocalcemia defined as ≥ 8.0 mg/dl.
Table IV. Protocol proposed for prospective treatment of post-operative 
hypocalcemia in patients undergoing total thyroidectomy.
• Measure pre-operative serum calcium (mg/dl).
• Measure post-operative serum calcium (mg/dl) on morning of first 
post-operative day.
• Calculate Δ as latest pre-operative serum calcium minus first post-
operative serum calcium.
• If Δ ≥ 1.1 mg/dl (reduction ≥ 12% compared to pre-operative level) 
give calcium gluconate i.v., and supplement orally with calcium 
and vitamin D twice a day. Measure serum calcium on morning of 
second post-operative day; if within normal range, reduce by 50% 
the Ca dose; if low, continue with oral Ca and Vitamin D; if patient 
becomes symptomatic add calcium gluconate i.v. If Δ < 1.1 mg/dl 
(reduction of < 12% compared to pre-operative level) no treatment 
but measure serum calcium on morning of second post-operative 
day (and if hypocalcemic start treatment).
• Measure serum calcium on morning of third post-operative day. 
If hypocalcemic, start treatment; if normocalcemic, discharge 
immediately after removal of drainage (third post-operative day).
• Measure serum calcium 24 hours after discharge (laboratory near 
patient’s home). If hypocalcemic, patient instructed to contact 
attending physician by telephone.predicting hypocalcemia after total thyroidectomy
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was reduced from 13 in the retrospective series to 4 in the 
prospective series (77% reduction).
Discussion
The aim of the present study was not to investigate the 
causes of hypocalcemia following total thyroidectomy but 
to identify, at an early stage, patients at high risk of devel-
oping post-operative hypocalcemia, in order to start treat-
ment and thereby avoid the clinical manifestations of the 
condition and permit a reduction in hospitalization time. 
For this reason, we did not select patients for age, sex, or 
type of thyroid disease and did not consider whether or 
not lateral or central neck dissection was performed.
There  is  considerable  controversy  concerning  which 
measurements to perform – and when – to predict tran-
sient  or  permanent  post-operative  hypoparathyroidism. 
Some Authors recommend intra-operative and peri-oper-
ative ipTh monitoring 7 9 12. Asari et al. measured ipTh 
levels, 24 hours after total thyroidectomy, and calcium 
levels, on the second post-operative day, and found that 
with these measurements it was possible to predict hypo-
parathyroidism with high sensitivity, specificity and posi-
tive  predictive  value  13.  however,  in  another  study,  no 
significant correlation was found between pTh levels 24 
hours after surgery and the development of significant 
hypocalcemia 8. yet another study supported the useful-
ness of ipTh monitoring, but noted that the high cost of 
monitoring represented a major limitation to clinical use 3. 
Serum calcium may be monitored instead of pTh. Some 
centres repeat serum calcium measurements for several 
days until a rising trend is observed 10 14; others discharge 
patients early on calcium replacement without prolonged 
calcium monitoring 2. nahas et al. 10 recommended an al-
gorithm involving calcium measurements, 6 and 12 hours 
post-operatively, to identify patients at risk of developing 
hypocalcemia.
From our retrospective evaluation of 100 patients, it was 
found that a maximum of 36 hours (morning of second 
post-operative day) was necessary to observe a decrease 
in serum calcium levels close to those expected to cause 
symptoms. more importantly, a marked decrease in serum 
calcium compared to pre-operative levels on the first post-
operative measurement (morning of first post-operative 
day) was a reliable predictor of subsequent hypocalcemia. 
we therefore studied the drop (Δ) in serum calcium be-
tween the last pre-operative assessment and that on the 
morning after surgery, and, after examining the distribu-
tion of Δ (Table iii) adopted a 1.1 mg/dl (12% of pre-op-
erative) as cut-off for predicting hypocalcemia and elabo-
rated a protocol in which calcium replacement was started 
immediately if the fall was ≥ 1.1 mg/dl. An important as-
pect of this protocol was that patients were discharged as 
soon as drainage was removed (usually the third day) if 
serum calcium was in the range 8.8-10.2 mg/dl.
Choice of the 1.1 mg/dl cut-off derived from our expe-
rience in the prospective series: 42/55 hypocalcemic pa-
tients had Δ ≥1.1 mg/dl and 9/12 patients who did not de-
velop post-operative hypocalcemia had Δ < 1.1 mg/dl. The 
difference in hypocalcemia was significant (p = 0.0013, 
Fisher’s exact test). Application of the protocol to our pro-
spective series resulted in a reduced number of calcium 
measurements (from a mean of 13/patient in the retro-
spective series to a mean of 3/patient in the prospective 
series (at a cost 12 euro per test) and most importantly 
reduced hospitalization time from 6.2 days to 4.7 days 
with a consequent cost reduction of approximately 1000 
euro/patient (hospitalization cost 500 euro/day). The pro-
portion of patients who developed symptomatic hypocal-
cemia dropped only slightly from the retrospective (24%) 
to the prospective (19.4%) series (Table i). The increase 
in the proportion of hypocalcemic patients, from 50% in 
the retrospective series to 82% in the prospective series 
(Table i) is almost certainly due to the change in the defi-
nition of hypocalcemia by the analytical laboratory (in-
creased from < 8.0 to < 8.8 mg/dl).
in  conclusion,  we  propose  herewith  assessment  of  the 
drop in calcium levels post-operatively compared to the 
immediate pre-operative levels as a useful and simple pre-
dictor of hypocalcemia in patients undergoing total thy-
roidectomy. Adoption of 1.1 mg/dl (12% of pre-operative 
level) as cut-off for determining whether to start prophy-
lactic calcium replacement, made it possible to discharge 
patients, on average, about 2 days earlier with a signifi-
cant saving in costs.
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